Your Search Returned 500 tagged news reports
People walk past a Western Union branch at Times Square in New York November 30, 2011. Eduardo Munoz Net income fell to $212 million, or 37 cents per share, in the first quarter, from $247.3 million, or 40 cents per share, a year earlier. Total
Tags:
All three Australian oval ball codes are caught up in peptide scandals, and the use of human growth hormone variants is said to be rife in boxing. As many as 31 NRL players at seven clubs are reportedly being investigated by the Australian Sports
Tags:
The drug giant, which has its largest worldwide research-and-development site in Groton, reported profits of $2.75 billion for the first three months of the year, a 53 percent increase from the same period last year. But the company lowered its
Tags:
has obtained approval of its treatment for Gaucher's disease, Uplyso, from the Mexican Federal Commission for the Protection against Sanitary Risk and the Public Health Institute of Chile...Uplyso, marketed in the US as Elelyso, is a long-term plant-
Tags:
US drugmakers Pfizer Inc and Merck & Co Inc said they would jointly develop Pfizer's experimental type 2 diabetes drug, ertugliflozin, and expect late-stage trials to start later in 2013. Pfizer has so far received $60 million in upfront and
Tags:
Phase 3 study was designed to assess the immunogenicity, tolerability and safety of Prevenar 13* in adults between 18 to 49 years of age. When measure one month succeeding vaccination, Prevenar 13 demonstrated minimum immunogenicity in the study
Tags:
S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves in
Tags:
This morning, the Labor Department reported that the number of jobless claims filed last week fell to the seconded lowest level in five years, at 339,000. This came as economists were expecting claims to come in at 351,000. The report indicates the
Tags:
Pfizer Inc. said Thursday that the European Union 's committee of medical experts has rejected the company's drug Xeljanz for patients with rheumatoid arthritis. The European Medicines Agency committee recommended against approving the drug because
Tags:
S&P Capital IQ. *Based on pro forma figures provided by Abbott...In recent months, analysts have had mixed views on AbbVie's earnings prospects, having reduced their estimates for the just-ended quarter by $0.03 per share but raising their full-year
Tags: